The Department of Nuclear Medicine and Molecular Imaging - University Medical Center Groningen is pleased to host a symposium dedicated to advances in Targeted Radionuclide Therapy (TRT), the ‘Groningen TRT Symposium 2027’. The meeting will bring together clinicians, researchers, medical physicists, radiochemists, and industry partners from across Europe and beyond to discuss recent advances and future directions in the field. Participants will discuss the latest developments in radionuclide production, radiochemistry and -pharmacy, molecular imaging, dosimetry, clinical translation and research, as well as an industry perspective.

Held at DOT Groningen from 7 to 9 April 2027, the scientific sessions will highlight emerging therapeutic radionuclides and radiopharmaceuticals, novel tumour targets, and combination strategies. Speakers will present cutting-edge preclinical research alongside the latest clinical trial results. Interactive sessions will provide opportunities to exchange ideas and foster new collaborations. Early-career researchers will have the opportunity to present their work during dedicated oral and poster sessions.

The meeting reflects UMCG's commitment to advancing precision oncology through innovation in nuclear medicine and molecular imaging. We look forward to welcoming participants to Groningen for an inspiring and collaborative scientific programme.

Organizer

University Medical Center Groningen
Department of Nuclear Medicine and Molecular Imaging
Langstraat 4 - EB50
Hanzeplein 1
9713 GZ Groningen
The Netherlands

Programme

Wednesday – Friday, 7-9 April 2027:

• Across the three days, keynote and invited speakers will discuss advances in radionuclide production, radiochemistry, dosimetry, radiobiology, and clinical applications. Combining these topics across days will create a varied programme and encourage exchange across the TRT community. Selected abstracts and poster presentations will provide researchers with an opportunity to present their findings.
• On Friday from 16:00, prof. dr. Bart Cornelissen will present his inaugural lecture at the Academy Building. 
• Full information about the program and all its details will be announced in this page.

Locations

• 7 – 9 April 2027
  DOT Groningen - Vrydemalaan 2, 9713 WS Groningen, The Netherlands
• 9 April 2027 from 3.45 pm
  Academic Building - Broerstraat 5, 9712 CP Groningen, The Netherlands

Speakers

We are delighted to present our confirmed speakers on the following page:

Speakers

Registration

The Groningen TRT Symposium 2027 is expected to be attended by maximum 234 participants from all over the world from research and academia, clinical practices, medical physics and technical expertise, and industry and innovation with wide area of interest in Targeted Radionuclide Therapy to gather and network, share knowledge and experiences, and showcase the results and products.

Registration fees

Register here

Call for abstracts

• Abstracts are invited in the fields of Radionuclide Production, Radiochemistry, Radiopharmacy, Dosimetry, Radiobiology and Clinical Applications, related to Radionuclide Therapy.
• The call for abstracts is now open. Submit your abstract by 21 January 2027 for consideration as an oral or poster presentation.
• Abstract submission details, template, and guidelines can be accessed by using the button below. The submission will be made by sending the abstract to [email protected] Abstract needs to be submitted using the template.

Abstract template

Call for sponsors

• The symposium welcomes sponsors from industries to participate in the Groningen TRT Symposium 2027.
• We facilitate some dedicated industrial packages for our industrial partners. Please contact us for further information.

Contact us

Send a message